ArticleFrontiers in medicine2026
Interpretable and explainable predictive machine learning models for gastric retention before gastroscopy.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early detection of gastric retention (GR) is challenging in clinical practice. We aimed to develop and validate interpretable machine learning (ML) models for predicting GR risk using routinely available clinical features. Methods: This retrospective study enrolled 3,233 consecutive patients (training cohort: Results: LASSO regression identified 12 clinically actionable predictors from 19 candidate variables, which were subsequently used to develop nine ML models. Among these models, the extreme gradient boosting (XGBoost) model achieved the highest AUC value of 0.710 (95% CI: 0.681-0.738) in the validation cohort. Decision curve analysis revealed that the XGBoost model exhibited superior clinical utility compared to other models. Shapley Additive Explanations (SHAP) identified the use of anticholinergic drugs, pyloric obstruction, analgesic use, systemic diseases, and a history of gastrointestinal surgery as the top five important predictive features. Conclusions: This study establishes an interpretable GR risk stratification model using routinely available preoperative variables. The model may serve as an auxiliary screening aid for pre-gastroscopy risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.